SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-046093
Filing Date
2014-07-31
Accepted
2014-07-31 16:05:47
Documents
8
Period of Report
2014-09-10
Effectiveness Date
2014-07-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A v384968_def14a.htm DEF 14A 306355
2 GRAPHIC tlogo.jpg GRAPHIC 10476
3 GRAPHIC tpg2.jpg GRAPHIC 10738
4 GRAPHIC tpg3.jpg GRAPHIC 10763
5 GRAPHIC tpg33.jpg GRAPHIC 10861
6 GRAPHIC proxy1.jpg GRAPHIC 242320
7 GRAPHIC proxy2.jpg GRAPHIC 224373
8 GRAPHIC proxy3.jpg GRAPHIC 283208
  Complete submission text file 0001144204-14-046093.txt   1400679
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 141006309
SIC: 2834 Pharmaceutical Preparations